If you have been living with HIV-1 for a while, you may know that treatment can fail you because HIV-1 can develop resistance. Once treatment fails, it may feel like getting your viral load back to undetectable* levels is out of reach.

With long-acting TROGARZO® (ibalizumab-uiyk), you could regain viral suppression, even if other antiretroviral therapies (ARTs) have failed you.

High of being low

When you have treatment failure, it is recommended that you modify your regimen as soon as possible to avoid further resistance.

The most effective HIV-1 treatment regimen is one that combines 3 active antiretroviral medicines. An active antiretroviral medicine could be a new type you haven't taken before.

Long-acting TROGARZO® is an HIV-1 treatment designed for patients with treatment failures. Together, you and your healthcare provider can decide if TROGARZO® should be part of your treatment regimen.

* Undetectable viral load is defined as fewer than 50 copies of HIV RNA per mL of blood.

Long-acting TROGARZO® facts:

Did you know:

  1. TROGARZO® is a different kind of ART, known as a biologic.
  2. TROGARZO® is the first and only long-acting antiviral for HIV-1 patients with treatment failures.
  3. TROGARZO® has demonstrated durable efficacy at reducing viral load.
  4. TROGARZO® is generally well tolerated, with a low incidence of adverse reactions.
  5. TROGARZO® is given every 2 weeks, allowing you to keep regular contact with your healthcare provider.

Continue reading below for more information about these long-acting TROGARZO® facts.

Long-acting TROGARZO® is in a class of its own

Unlike other types of antiretroviral medications, TROGARZO® is a biologic -- An antibody bioengineered specifically to protect your T-cells from the virus.

Long-acting TROGARZO® is a breakthrough in HIV-1 treatment

TROGARZO is used in combination with other antiretroviral medicines to treat HIV-1 infection in adults who:

Trogarzo requirements

Lighten the viral load

In a clinical study, TROGARZO® was proven to have a significant and long-lasting impact on the amount of HIV-1 in the body.

83% of patients were able to reduce their HIV-1 viral load after a single dose of long-acting TROGARZO®.

In addition, those patients who reached undetectable viral load levels were able to remain undetectable over time.

Proven safety profile

TROGARZO is generally well tolerated. 90% of reported adverse reactions were mild or moderate, and included diarrhea, dizziness, nausea and rash.

TROGARZO® does not interact with other drugs, so you can take it with other medications you may be taking. Make sure you discuss your other medications with your doctor before taking TROGARZO®.

TROGARZO® is the first and only long-acting antiviral against HIV-1.

The way you take long-acting TROGARZO is different. It's not a pill, it is an intravenous infusion, given over 15 to 30 minutes every 2 weeks.

Trogarzo care steps

Your infusion appointments are a great opportunity to talk to your HCP about how you feel with your treatment and ask any HIV-1 related questions your may have.

THERA patient support® IS HERE TO HELP

Once long-acting TROGARZO® becomes a part of your regimen, you'll receive a welcome call from your dedicated Patient care coordinator.

THERA patient support® can also assist with your private or government insurance coverage, including AIDS Drug Assistance Program (ADAP) and will also assist in applying any eligible co-pay assistance.

From appointment reminders to insurance coverage assistance, and anything in between, our knowledgeable team is here to help.

With long-acting TROGARZO® you can lighten your viral load and make undetectable a possibility again. Talk to your healthcare provider about TROGARZO® today.

To discover Nelson's TROGARZO® (ibalizumab-uiyk) experience, visit trogarzo.com.

IMPORTANT SAFETY INFORMATION

What is TROGARZO®?

TROGARZO® (ibalizumab-uiyk) is a prescription medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults who:

  • have received anti-HIV-1 regimens in the past, and
  • have HIV-1 virus that is resistant to antiretroviral medicines, and
  • who are failing their current antiretroviral therapy

It is not known if TROGARZO® is safe and effective in children.

Do not receive TROGARZO® if you have had an allergic reaction to TROGARZO® or any of the ingredients in TROGARZO®.

TROGARZO® can cause serious side effects, including:

  • Allergic reactions. TROGARZO® can cause allergic reactions, including serious reactions, during and after infusion. Tell your healthcare provider or nurse, or get medical help right away if you get any of the following symptoms of an allergic reaction:
    • trouble breathing
    • swelling in your throat
    • wheezing
    • chest pain
    • chest tightness
    • cough
    • hot flush
    • nausea
    • vomiting
  • Changes in your immune system (Immune Reconstitution Inflammatory Syndrome) can happen when you start taking HIV-1 medicines. Your immune system might get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your health care provider right away if you start having new symptoms after receiving TROGARZO®.

The most common side effects of TROGARZO® include diarrhea, dizziness, nausea, and rash. These are not all the possible side effects of TROGARZO®.

Before you receive TROGARZO®, tell your healthcare provider about all of your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if TROGARZO® may harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with TROGARZO®.
  • Breastfeeding or plan to breastfeed. You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Do not breastfeed if you are receiving TROGARZO® as it is not known if TROGARZO® passes into breast milk. Talk with your healthcare provider about the best way to feed your baby during treatment with TROGARZO®.

Also, tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

For more information or medical advice about side effects, ask your healthcare provider. You may report side effects to the FDA at 1-800-FDA-1088 or the THERA patient support® at 1-833-23THERA (1-833-238-4372).

Please see full Prescribing Information for TROGARZO®.

TROGARZO® is a registered trademark of TaiMed Biologics Inc., under license to Theratechnologies Inc.

THERA Patient Support is a trademark of Theratechnologies Inc.

© 2020 Theratechnologies Inc. All rights reserved.

749-02-07/20

WebMD does not endorse any specific product, service, or treatment.